41.43
41.43 (0%)
As of Feb 14, 2025
Biohaven Ltd. [BHVN]
Source:
Company Overview
Biohaven Ltd. is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.
| Country | United States |
| Headquarters | new haven, connecticut |
| Phone Number | 203-404-0410 |
| Industry | |
| CEO | Vlad Coric, M.D. |
| Website | www.biohavenpharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-885.1 |
| Net Income | $-846.4 |
| Net Cash | $-149.6 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -150% |
| Profit as % of Stockholder Equity | -199.9% |
Management Effectiveness
| Return on Equity | -199.9% |
| Return on Assets | -137.6% |
| Turnover Ratio | |
| EBITA | $-885.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $615.1 |
| Total Liabilities | $191.7 |
| Operating Cash Flow | $-582.5 |
| Investing Cash Flow | $-245 |
| Financing Cash Flow | $677.8 |
